Results 21 to 30 of about 229,156 (278)

In dogs with chronic enteropathy (idiopathic inflammatory bowel disease) is budesonide more effective than prednisolone or prednisone in resolving clinical signs?

Veterinary Evidence, 2023
PICO Question In dogs with chronic enteropathy (idiopathic inflammatory bowel disease) is budesonide more effective than prednisolone or prednisone in resolving clinical signs or improving the canine inflammatory bowel disease (IBD) activity index ...
Victoria Alice Coates
doaj   +1 more source

Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation [PDF]

, 2016
Although defects in intestinal barrier function are discussed as a key pathogenic factor in patients with inflammatory bowel diseases (IBD), the molecular pathways driving disease-specific alterations of intestinal epithelial cells (IECs) are largely ...
Alastair J.M. Watson, Arif B. Ekici, Becker, Christoph Becker, Claudia Günther, Cord Brakebusch, Distler, Gionata Fiorino, Heller, Hopkins, Imke Atreya, Kerstin Amann, Lin, Markus F. Neurath, Martin Bergö, Ohkusa, Pastorelli, Pechlivanis, Raja Atreya, Rocío López-Posadas, Silvio Danese, Stefan Tenzer, Stefan Wirtz, Stefania Vetrano, Turcotte, Ulrike Billmeier, Veronika Thonn, Zverina   +27 more
core   +1 more source

The Information Needs and Preferences of Persons with Longstanding Inflammatory Bowel Disease

Canadian Journal of Gastroenterology, 2012
BACKGROUND: Understanding the information needs and preferred vehicles of information delivery to patients with inflammatory bowel disease (IBD) will enhance their care.
Samantha Wong, John R Walker, Rachel Carr, Lesley A Graff, Ian Clara, Stephen Promislow, Linda Rogala, Norine Miller, Patricia Rawsthorne, Charles N Bernstein   +9 more
doaj   +1 more source

Physical Exercise Does Not Improve Colon Inflammation in Mice Induced Lambda Carrageenan

Jurnal Medik Veteriner, 2020
Inflammatory Bowel Disease (IBD) is a well known reported gastrointestinal tract disease, which the prevalence continous to increase in Southeast Asia and other developing countries.
Ana Qonitatillah, Kristanti Wanito Wigati, Roedi Irawan   +2 more
doaj   +1 more source

Assessing the Relationship between Sources of Stress and Symptom Changes among Persons with IBD over Time: A Prospective Study

Canadian Journal of Gastroenterology and Hepatology, 2016
Objective. To describe the sources of stress for persons with IBD and changes with changes in symptoms. Methods. 487 participants were recruited from a population-based IBD registry.
Matthew T. Bernstein, Laura E. Targownik, Kathryn A. Sexton, Lesley A. Graff, Norine Miller, John R. Walker   +5 more
doaj   +1 more source

Serrated Adenoma Prevalence in Inflammatory Bowel Disease Surveillance Colonoscopy, And Characteristics Revealed by Chromoendoscopy and Virtual Chromoendoscopy

Canadian Journal of Gastroenterology and Hepatology, 2014
BACKGROUND: Sessile or nonpolypoid neoplastic lesions, including sessile serrated adenomas (SSAs), are difficult to detect in patients with inflammatory bowel disease (IBD).
Marietta Iacucci, Cesare Hassan, Miriam Fort Gasia, Stefan Urbanski, Xianyong Gui, Bertus Eksteen, Gregory Eustace, Gilaad G Kaplan, Remo Panaccione   +8 more
doaj   +1 more source

Evaluation of the functional activity of CD39 ectonucleotidase in regulatory T cells in children with inflammatory bowel diseases

Медицинская иммунология, 2023
In connection with the increasing incidence and prevalence of inflammatory bowel disease (IBD), the search for prognostic markers of the effectiveness of therapy is an urgent problem. An imbalance between Th17 lymphocytes and regulatory T cells (Treg) is
T. V. Radygina, E. G. Sorokina, S. V. Petrichuk, D. G. Kuptsova, O. V. Kurbatova, A. S. Potapov, S. A. Afanasyeva   +6 more
doaj   +1 more source

Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease [PDF]

, 2012
Background and Aims:We analyzed iron deficiency and the therapeutic response following intravenous ferric carboxymaltose in a large single-center inflammatory bowel disease (IBD) cohort.
Anker SD, Anker SD, Beate Löhr, Breymann C, Burkhard Göke, Carrier J, Chandler G, Cornelia Tillack, De Silva AD, Domenech E, Erichsen K, Erichsen K, Evstatiev R, Fabian Schnitzler, Fleming MD, Fleming RE, Florian Beigel, Ganz T, Gasche C, Gasche C, Julia Seiderer, Katsanos K, Kociol RD, Kulnigg S, Lomer MC, Maria Weidinger, Nemeth E, Nemeth E, Pizzi LT, Qunibi WY, Qunibi WY, Rüdiger P. Laubender, Schroder O, Semrin G, Simone Breiteneicher, Srigiridhar K, Stein J, Stephan Brand, Szczech LA, Tagboto S, Thomas Ochsenkühn, Van Wyck DB, Wells CW, Werner T, Wilson A, Wilson A   +45 more
core   +1 more source

Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD [PDF]

, 2016
The consistent technical and conceptual progress in the study of the microbiota has led novel impulse to the research for therapeutical application of probiotic bacteria in human pathologies, such as inflammatory bowel disease (IBD).
DELLE FAVE, Gianfranco, Lanini, Claudio, Martorelli, M, Pagnini, C   +3 more
core   +1 more source

Challenges in IBD Research: Preclinical Human IBD Mechanisms [PDF]

Inflammatory Bowel Diseases, 2019
Preclinical human IBD mechanisms is part of five focus areas of the Challenges in IBD research document, which also include environmental triggers, novel technologies, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD ...
Pizarro, Theresa T., Stappenbeck, Thaddeus S., Rieder, Florian, Rosen, Michael J., Colombel, Jean-Frédéric, Donowitz, Mark, Towne, Jennifer, Mazmanian, Sarkis K., Faith, Jeremiah J., Hodin, Richard A., Garrett, Wendy S., Fichera, Alessandro, Poritz, Lisa S., Cortes, Constanza J., Shtraizent, Nataly, Honig, Gerard, Snapper, Scott B., Hurtado-Lorenzo, Andrés, Salzman, Nita H., Chang, Eugene B.   +19 more
openaire   +3 more sources